Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cholangiocarcinoma × Doxorubicin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 165 Lymphoma, Large B-Cell, Diffuse 90 Lymphoma 90 Precursor Cell Lymphoblastic Leukemia-Lymphoma 72 Sarcoma 60 Hodgkin Disease 50 Lymphoma, Non-Hodgkin 35 Triple Negative Breast Neoplasms 33 Burkitt Lymphoma 33 Leukemia 31 Lymphoma, Mantle-Cell 30 Lymphoma, Follicular 28 Carcinoma, Hepatocellular 26 Multiple Myeloma 23 Ovarian Neoplasms 19 Neoplasms 18 Neoplasm Metastasis 18 Prostatic Neoplasms 17 Osteosarcoma 16 Lymphoma, Large-Cell, Anaplastic 16 Lymphoma, B-Cell 14 Neuroblastoma 13 Lymphoma, Large-Cell, Immunoblastic 13 Urinary Bladder Neoplasms 12 Lymphoma, T-Cell, Peripheral 12 Immunoblastic Lymphadenopathy 12 Inflammatory Breast Neoplasms 11 Stomach Neoplasms 10 Recurrence 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9

Interventions

Gemcitabine 69 Cisplatin 41 Oxaliplatin 31 lenvatinib 22 durvalumab 21 Capecitabine 21 Fluorouracil 18 Leucovorin 13 pembrolizumab 10 apatinib 10 Radiotherapy 10 Radiofrequency Ablation 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Taxes 7 Magnetic Resonance Spectroscopy 7 Liver Transplantation 7 Floxuridine 7 Drug Therapy 7 Cholangiopancreatography, Endoscopic Retrograde 7 tremelimumab 6 pemigatinib 6 Surgical Procedures, Operative 6 Photochemotherapy 6 Panitumumab 6 Irinotecan 6 Folfox protocol 6 130-nm albumin-bound paclitaxel 6 sintilimab 5 camrelizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01920503 2019-02-27

CHOLANGIO

International Group of Endovascular Oncology

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡